Trump Reportedly Nearing Federal Marijuana Rescheduling

Recent reports indicate that President Donald Trump is considering rescheduling marijuana under federal law, a move that could significantly reshape the U.S. cannabis industry.

According to Marijuana Business Daily, citing reporting from The Washington Post, President Trump is weighing an executive order that would reclassify marijuana from Schedule I to Schedule III under the Controlled Substances Act. Schedule I substances are defined as having no accepted medical use and a high potential for abuse, while Schedule III drugs are considered to have accepted medical uses and lower abuse potential.

While rescheduling would not legalize cannabis at the federal level, it could ease restrictions on scientific research, reduce regulatory burdens, and provide major financial relief to licensed cannabis operators. Most notably, Schedule III status could allow cannabis businesses to claim standard tax deductions currently prohibited under IRS Code Section 280E.

The report suggests that Trump discussed the issue during conversations with House Speaker Mike Johnson, with cannabis industry executives present. However, White House officials have emphasized that no final decision has been made, and any policy shift would still require coordination with federal agencies such as the Drug Enforcement Administration.

The potential change has already had ripple effects across the market, with cannabis stocks reacting positively to the news. Industry advocates argue that rescheduling would better align federal law with the reality that the majority of U.S. states have legalized marijuana for medical or adult use.

If enacted, rescheduling marijuana to Schedule III would represent one of the most consequential federal cannabis policy changes in decades, signaling a significant shift in the federal government’s approach to marijuana regulation.

Sources

– Marijuana Business Daily – Report: President Trump close to marijuana rescheduling (Dec. 11, 2025)

– The Washington Post – Trump seeks to cut restrictions on marijuana through planned order

– Reuters – Cannabis stocks surge on report Trump seeks to ease restrictions

– Axios – Trump leans toward reclassifying marijuana

– Forbes – White House says no final decisions on marijuana rescheduling

If you are interested in learning more: Schedule a Consultation today!

The Cannabis Business Advisors have more than thirty years of combined industry experience, spanning across the U.S. and around the globe. C.B. Advisors offers a comprehensive suite of services, including application and licensing preparation, operational analysis, merger and acquisition support, policy and procedures, exit strategy guidance, and business development planning. Stay up to date on the latest cannabis news with The CB Advisors!

Contact Info@thecannabisbusinessadvisors.com for more information on how to apply for a cannabis business license.

[/vc_column_text][/vc_column][/vc_row]